A potential weapon against Alzheimer’s disease could be hidden in aloe vera, scientists recently uncovered. Aloe vera, a rubbery green plant, may be best known for its skin-soothing qualities, but a ...

A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...

Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...

To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe ...

Our most recent episode of The Expert Series podcast “Your Lupus Treatment Roadmap: Understanding the New Guidelines and What They Mean for You” explores the newly released SLE treatment guidelines ...

ROCHESTER — Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart ...

Scientists looking to provide relief for people with inflammatory bowel disease have turned to an unusual source for inspiration: barnacles. Inflammatory bowel disease (IBD), such as Crohn’s disease ...

Panelists discuss how APPs balance emerging therapies and supportive care to optimize Alzheimer treatment. Panelists discuss how treatment selection must balance safety, tolerability, and ...

Huntington's disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a progressive, hereditary brain disease that affects movement, cognition and emotions.

Barbara Jacquelyn Sahakian receives funding from the Wellcome Trust. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health and Neurodegeneration ...

This past spring, a biotech company announced the first use of a new gene-editing technology in people to fix an errant gene that causes a severe immune disorder. In June, a baby born with a ...

To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com CNBC Cures aims to help raise awareness of rare diseases and improve patient outcomes for people living ...